Inari Medical, Inc. (NARI) Misses Q4 EPS by 9c, Beats on Revenue

Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of ($0.08), $0.09 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $132.1 million versus the consensus estimate of $131.76 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Hermès can regain momentum despite China weakness, Jefferies says